Post-approval studies (Phase 4)Looking for participantsNCT07689578
What this trial is testing
Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) in Kidney Transplant Recipients With Chronic Active Antibody-Mediated Rejection
Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Turun Song 50